Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy
Jinghua Jiao,Honghua Yu,Litong Yao,Lihua Li,Xiaohong Yang,Lei Liu
DOI: https://doi.org/10.2147/JIR.S336148
IF: 4.5
2021-12-16
Journal of Inflammation Research
Abstract:Jinghua Jiao, 1, &ast Honghua Yu, 2, &ast Litong Yao, 3, &ast Lihua Li, 4 Xiaohong Yang, 2 Lei Liu 2 1 Department of Anesthesiology, Central Hospital, Shenyang Medical College, Shenyang, Liaoning, 110024, People's Republic of China; 2 Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510120, People's Republic of China; 3 Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, People's Republic of China; 4 Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, 261031, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaohong Yang; Lei Liu Email ; The microbiome has become a hot issue in recent years. The composition, modification, alteration, and disturbance of gut microbiota were found to influence important physiological processes, including energy metabolism and microenvironmental homeostasis, and lead to various diseases, including obesity, type 2 diabetes mellitus and chronic kidney disease. Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and one of the leading causes of blindness and vision impairment. The underlying mechanisms in DR pathogenesis remain limited. Recently, important insights have been made regarding possible connections between gut microbiome dysbiosis and ocular disease including DR, uveitis, glaucoma, and age-related macular degeneration, and the concept of a "microbiota–gut–retina axis" has been put forward. Hence, we reviewed current understanding of the relationship between DR and gut microbiota. We summarized potential pathophysiological mechanisms that contribute to the role of the gut microbiota on DR, including hyperglycemia, anti-diabetes drugs, microbial metabolites, and inflammatory properties. We aimed to find novel effective therapeutic options to prevent the onset and development of DR. Keywords: retinopathy, bacteria, microbiota, microbiota–gut–retina axis, mechanism Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus (DM), 1 and it is estimated that there will be nearly 191 million people with the disease by 2030. 2,3 In addition, DR has become one of the leading causes of blindness and vision impairment in the working age population. 4–6 A recent report indicated that cases of blindness due to DR may cost up to $500 million annually in the United States. 7 Based on current epidemiologic investigations and clinical studies, the onset and progression of DR is complicated and has been associated with various factors, including duration of disease, glycemia and blood pressure control. 8,9 However, the underlying molecular mechanisms in DR pathogenesis remain limited and unclear. The lack of effective therapeutic options for the prevention of DR necessitates further investigation of pathological mechanisms and effective approaches that would provide new therapeutic strategies against DR. The microbiome has become a hot issue of concern for research in recent years. Previous evidence has demonstrated that the composition, modification and disturbance of gut microbiota affect important physiological processes, including energy metabolism and microenvironmental homeostasis. 10,11 The gut dysbiosis held great significance in susceptibility to and development of various diseases in vivo in rodent and human studies, including obesity, type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD) 12,13 and rheumatoid arthritis (RA). 14 Subsequent studies reported that gut microbiota could lead to chronic inflammation and imbalance of immune system referring to small-molecule constituents such as short-chain fatty acids (SCFA) and secondary bile acids and trim-ethylamine. 15 The relationship between gut microbiota and ocular abnormalities including uveitis, glaucoma, and age-related macular degeneration (AMD) has been increasingly revealed, and the concept of a "microbiota–gut–retina axis" has been put forward. 16,17 However, little has been understood regarding the molecular mechanisms of intestinal dysbiosis and how they induce retinopathy in patients with DM. Recently, data indicate that changes in the gut microbiome act as a key internal environmental modulator which favorably affects the pathogenetic processes underlying the micro-complications of DM such as DR. 18 In this review, we propose to highlight the several potential pathophysiological mechanisms that contribute to the influence -Abstract Truncated-
immunology